Kazia Therapeutics Limited (KZIA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kazia Therapeutics Limite...

    NASDAQ: KZIA · Real-Time Price · USD
    6.56
    0.25 (3.96%)
    At close: Oct 03, 2025, 3:59 PM
    6.36
    -3.05%
    Pre-market: Oct 06, 2025, 07:21 AM EDT

    Kazia Therapeutics Cash Flow Statement

    Financials in AUD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020
    Net Income
    		 -23.18M -26.78M -15.7M -20.47M -25.4M -25.01M -15.26M -8.42M -12.95M
    Depreciation & Amortization
    		 1.4M 1.87M 1.87M 1.87M 1.87M 1.87M 1.66M 1.27M 1.08M
    Stock-Based Compensation
    		 328.73K 533K 650.86K 1.16M 1.98M 1.67M 971.99K 636.38K 364.01K
    Other Working Capital
    		 431.89K -470K -4.23M 584.09K 5.26M 1.76M 7.36M -1.09M -8.43M
    Other Non-Cash Items
    		 13.81M 15.26M 352.79K -1.75M -4.88M -2.7M 5.05M -4.58M -7.41M
    Deferred Income Tax
    		 n/a n/a -2.16M -2.3M -1.48M -332.44K 3.85M 1.55M -937.12K
    Change in Working Capital
    		 184.55K -465K 144.7K 4.03M 6.25M 1.41M -648.42K 1.99M 573.11K
    Operating Cash Flow
    		 -7.46M -9.58M -12.68M -15.16M -20.18M -22.76M -8.23M -9.11M -18.34M
    Capital Expenditures
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a 5.24M 5.24M n/a -782.45K -782.73K -278 n/a n/a
    Investing Cash Flow
    		 n/a 5.24M n/a 2.12M 6.58M -782.73K 23.48M 25.71M 2.23M
    Debt Repayment
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 5.49M 5.37M 11.87M 12.97M 9.56M 3.73M 4.52M 28.11M 32.01M
    Financial Cash Flow
    		 5.49M 5.37M 11.87M 12.97M 9.56M 3.73M 4.52M 28.1M 32M
    Net Cash Flow
    		 n/a 3.56M -402.58K 425.34K -14.71M -23.54M 3.79M 21.04M 18.48M
    Free Cash Flow
    		 -7.46M -9.58M -12.68M -15.16M -20.18M -22.76M -8.23M -9.11M -18.34M

    Add to Watchlist